Literature DB >> 27372636

Assessment of general movements and heart rate variability in prediction of neurodevelopmental outcome in preterm infants.

Lidija Dimitrijević1, Bojko Bjelaković2, Hristina Čolović1, Aleksandra Mikov3, Vesna Živković1, Mirjana Kocić1, Stevo Lukić4.   

Abstract

BACKGROUND: Adverse neurologic outcome in preterm infants could be associated with abnormal heart rate (HR) characteristics as well as with abnormal general movements (GMs) in the 1st month of life. AIMS: To demonstrate to what extent GMs assessment can predict neurological outcome in preterm infants in our clinical setting; and to assess the clinical usefulness of time-domain indices of heart rate variability (HRV) in improving predictive value of poor repertoire (PR) GMs in writhing period. STUDY
DESIGN: Qualitative assessment of GMs at 1 and 3 months corrected age; 24h electrocardiography (ECG) recordings and analyzing HRV at 1 month corrected age.
SUBJECTS: Seventy nine premature infants at risk of neurodevelopmental impairments were included prospectively. OUTCOME MEASURES: Neurodevelopmental outcome was assessed at the age of 2 years corrected. Children were classified as having normal neurodevelopmental status, minor neurologic dysfunction (MND), or cerebral palsy (CP).
RESULTS: We found that GMs in writhing period (1 month corrected age) predicted CP at 2 years with sensitivity of 100%, and specificity of 72.1%. Our results demonstrated the excellent predictive value of cramped synchronized (CS) GMs, but not of PR pattern. Analyzing separately a group of infants with PR GMs we found significantly lower values of HRV parameters in infants who later developed CP or MND vs. infants with PR GMs who had normal outcome.
CONCLUSIONS: The quality of GMs was predictive for neurodevelopmental outcome at 2 years. Prediction of PR GMs was significantly enhanced with analyzing HRV parameters.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  General movements; Heart rate variability; Neurodevelopmental outcome; Preterm infant

Mesh:

Year:  2016        PMID: 27372636     DOI: 10.1016/j.earlhumdev.2016.05.014

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  6 in total

1.  Fetal-growth-restricted preterm infants display compromised autonomic cardiovascular control on the first postnatal day but not during infancy.

Authors:  Emily Cohen; Flora Y Wong; Euan M Wallace; Joanne C Mockler; Alexsandria Odoi; Samantha Hollis; Rosemary S C Horne; Stephanie R Yiallourou
Journal:  Pediatr Res       Date:  2017-04-07       Impact factor: 3.756

Review 2.  Early Diagnosis of Cerebral Palsy in Low- and Middle-Income Countries.

Authors:  Arrabella R King; Mahmudul Hassan Al Imam; Sarah McIntyre; Catherine Morgan; Gulam Khandaker; Nadia Badawi; Atul Malhotra
Journal:  Brain Sci       Date:  2022-04-23

3.  Osteopathic Manipulative Treatment Regulates Autonomic Markers in Preterm Infants: A Randomized Clinical Trial.

Authors:  Andrea Manzotti; Francesco Cerritelli; Erica Lombardi; Elena Monzani; Luca Savioli; Jorge E Esteves; Matteo Galli; Simona La Rocca; Pamela Biasi; Marco Chiera; Gianluca Lista
Journal:  Healthcare (Basel)       Date:  2022-04-27

4.  Combining Recurrence Analysis and Automatic Movement Extraction from Video Recordings to Study Behavioral Coupling in Face-to-Face Parent-Child Interactions.

Authors:  David López Pérez; Giuseppe Leonardi; Alicja Niedźwiecka; Alicja Radkowska; Joanna Rączaszek-Leonardi; Przemysław Tomalski
Journal:  Front Psychol       Date:  2017-12-19

Review 5.  PREDICTIVE VALUE OF THE GENERAL MOVEMENTS ASSESSMENT IN PRETERM INFANTS: A META-ANALYSIS.

Authors:  Camila da Silva Pires; Sérgio Tadeu Martins Marba; Jamil Pedro de Siqueira Caldas; Mônica de Carvalho Sanchez Stopiglia
Journal:  Rev Paul Pediatr       Date:  2020-05-08

Review 6.  Neonatal heart rate variability: a contemporary scoping review of analysis methods and clinical applications.

Authors:  Samantha Latremouille; Justin Lam; Wissam Shalish; Guilherme Sant'Anna
Journal:  BMJ Open       Date:  2021-12-21       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.